0845-460-6113

Clinical Studies

Validated to Lower Blood Pressure in 10 Clinical Studies

  • Ten clinical studies with peer-reviewed, published results have assessed the safety and efficiency of lowering high blood pressure in patients, whether taking medication or not.
  • Over 200,000 users prior to NHS decision to include on UK's drug tariff.

Dr. Elliott discusses the results of a RESPeRATE clinical study at the American Society of Hypertension 2002 Annual Meeting.

  • Dr. William Elliott
    Chicago, Illinois, USA
    Director, Rush University Hypertension Center

Studies design:

  • Clinical studies design included five randomized controlled trials, 1,2,5, 7one controlled4 and four open-label.3,6, 8,9
  • The controlled studies compared 8-week 15-minute daily treatment with RESPeRATE with control group, using Walkman with relaxing music1, home blood pressure monitor4,5 or both2.
  • There were a total of 507 participants, mean age of 58 (25 to 75); 78% on antihypertensive medication, of whom 1/3 on 3 or more medications.
  • Average initial office blood pressure was 150/90 mmHg despite other therapies, diet, exercise and/or medications.

Studies results:

  • RESPeRATE users with uncontrolled blood pressure experienced a significant decrease in office blood pressure with mean reduction of 14/8 mmHg (versus 9/4 mmHg in control), independently of gender and medication status.
  • Greater reductions for older patients (18/8 mmHg for age>65). 10
  • Of patients classified as stage 1 and 2, 46% and 26% achieved the blood pressure goal (<140/90 mmHg), respectively.11
  • The drop in office blood pressure displayed dose-response relationship with the duration of slow breathing: Those who used RESPeRATE more achieved greater reductions.5
  • A clinically significant sustained reduction in blood pressure typically occurred in 3 to 4 weeks.
  • Effective for resistant hypertension,6 isolated systolic hypertension,5 diabetes with hypertension7 and white-coat hypertension.12
  • All-day, lasting blood pressure lowering effect observed at the clinic, 1-9 home,2-4, 6 and with 24-hour ambulatory blood pressure measurements.3,9 Benefit and compliance were demonstrated over 6-month follow up. 13
  • No observed side effects.1-9

See Indications and administration guidelines >>

RESPeRATE Peer-Reviewed Articles

(All links open in a new window)

1. "Treating hypertension with a device that slows and regularizes breathing: A randomised, double-blind controlled study." Schein M, Gavish B, Herz M, Rosner-Kahana D, Naveh P, Knishkowy B, Zlotnikov E, Ben-Zvi N, Melmed RN. Journal of Human Hypertension; 2001, 15:271-278.
2. "Breathing-control lowers blood pressure." Grossman E, Grossman A, Schein MH, Zimlichman R, Gavish B. Journal of Human Hypertension; 2001, 15:263-269.
3. "Device-guided breathing exercises reduce blood pressure - Ambulatory and home measurements." Rosenthal T, Alter A, Peleg E, Gavish B.American Journal of Hypertension; 2001, 14:74-76.
4. "Nonpharmacologic Treatment of Hypertension by Respiratory Exercise in the Home Setting." E Meles, C Giannattasio, M Failla, G Gentile, A Capra, G Mancia. American Journal of Hypertension; 2004, 17:370-374.
5. "Graded Blood Pressure Reduction in Hypertensive Outpatients Associated with Use of a Device to Assist with Slow Breathing." W Elliott, J Izzo, Jr., WB White, D Rosing, CS Snyder, A Alter, B Gavish, HR Black. J Clin Hypertens; 2004 6(10): 553-559.
6. "Non-Pharmacological Treatment of Resistant Hypertensives by Device-Guided Slow Breathing Exercises." Viskoper , R, Shapira, I, Priluck, R, Mindlin, R, Chornia, L, Laszt, A, Dicker, D, Gavish, B, Alter, A. American Journal of Hypertension; 2003; 16:484-487.
7. Treating hypertension in type II diabetic patients with device-guided breathing: a randomized controlled trial.Schein MH, Gavish B, Baevsky T, Kaufman M, Levine S, Nessing A, Alter A.J Hum Hypertens 2009;23:325-331.
8. Effect of device-guided breathing exercise on blood pressure control: Korean multi-center study. Bae JH, Kim JH, Choe KH, Hong SP, Ko JK, Kim CH, Kim SH.Korea Hyperten J 2006, 1:19-23.
9. Device-guided paced breathing reduces blood pressure: ambulatory and office measurements.Aydin L, Kürklü A, Şengül A, Altuntaş Y, Erdine S. J Hyperten 2008;26:S371-S372.
10. Device-Guided Breathing to Lower Blood Pressure: Case Report and Clinical Overview.Elliott W, Izzo J Jr. Medscape General Medicine 2006; 8(3).
11. Treating high blood pressure by device-guided paced breathing in the home setting: Evidence-based approach.Schein M, Grossman E, Rosenthal T, Giannattasio C, Elliott W, Viskoper R, Alter A, Gavish B. J of Hum Hyperten 2005:19, 845–846.
12. Reduction of home blood pressures and white coat effect after 8 weeks of device-guided paced breathing. W Elliott, B Gavish, A Alter, J L. Izzo, and H R. Black, American Journal of Hypertension 2005, 18(5): 211A.
12. Effect of a 24 week of respiration training on arterial pressure of primary hypertensives. Giannattasio C, Boffi L, Corsi D, Fantini E, Maserroni S, Capra A, Failla M, Mancia G. Italian Society of Hypertension national meeting, Bologna, Italy, 24-27 September 2002.

Recent Publications

RESPeRATE: nonpharmacological treatment of hypertension. Cardiology in Review. 2011;19:47-51.


Impact of device-guided slow breathing on symptoms of chronic heart failure: a randomized, controlled feasibility study. European Journal of Heart Failure 2011;13:1000-1005.


Sympathetic nerve activity is decreased during device-guided slow breathing. Hypertension Research. 2010;33:708-712

Pooled characteristics of study patient population on enrollment

Pooled # of patients** 507
% Male 56%
Age (average) 57±11
Age in Years (%) <40 4%
40-60 54%
>60 42%
% Medicated 74%
No. of meds 1 med 34%
2 med 37%
>3 meds 29%
Systolic BP (mmHg) 150±12
Diastolic BP (mmHg) 89±9

Significant Blood Pressure Reductions

Consistent in 10 Clinical Studies

All-Day Sustained Home Blood Pressure Reduction in 3-4 Weeks

Get Clinical Info Pack

email